Alpha-2-adrenergic agonists appear to be effective at reducing symptoms associated with ADHD in preschool-aged children, and have fewer side effects than traditional stimulants used to treat ADHD.
A new study reveals adults with ADHD have an increased risk of developing nervous system, respiratory, musculoskeletal, and metabolic diseases. ADHD was also associated with a slightly increased risk of Parkinson's disease, dementia, and cardiovascular disease.
Lisdexamfetamine, a drug known to stimulate brain activity, reduces symptoms of sluggish cognitive tempo in adults with ADHD.
A new study of male guppies reveals behaviors affected by methylphenidate hydrochloride (MPH), an active ingredient in common ADHD medications, can be passed along to future generations.
Children who snore while they sleep have thinner gray matter in several areas of the frontal lobes. Significantly, the reduction in gray matter correlated with behavioral problems associated with sleep apnea. Some behavioral problems experienced include hyperactivity, increased aggression, and attention deficits.
Prenatal exposure to heavy metals such as cadmium, lead, and arsenic, and increased levels of the mineral manganese, were linked to an increased risk of ADHD and autism spectrum diagnosis in children.
Children who experience cognitive difficulties, such as attention problems or problems with working memory, have an increased risk of developing mental health disorders as young adults.
Children who grew up in residential areas surrounded by green space were less likely to be diagnosed with ADHD than those who were raised in areas without access to nature.
Study identifies a neural pathway associated with error monitoring and attention function in some psychiatric disorders such as ADHD, ASD, and schizophrenia. Researchers say the pathway could be modulated with the help of transcranial magnetic stimulation or transcranial direct current stimulation.